Patent applications filing share after FDA approval top drugs U.S. 2024

Percentage of patent applications for select top-selling drugs filed after FDA approval until 2024

Patent filing percentage after FDA approval among top selling U.S. until 2024

Last update:

Jul 4, 2025

Author:

��ƽ�� Research Department

Region:

United States

Survey time period:

From 01/01/1998 to 30/06/2024

As of May/June 2024, 94 percent of patent applications for top-selling drug Enbrel were filed after FDA approval in the United States. This statistic illustrates the percentage of applications filed after FDA approval among select top-selling drugs in the United States.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Percentage of patent applications for select top-selling drugs filed after FDA approval until 2024

Get in touch with us for additional information

��ƽ��